[go: up one dir, main page]

WO2002005746A3 - Procede de fabrication des tannates de qualite pharmaceutique - Google Patents

Procede de fabrication des tannates de qualite pharmaceutique Download PDF

Info

Publication number
WO2002005746A3
WO2002005746A3 PCT/IB2001/001252 IB0101252W WO0205746A3 WO 2002005746 A3 WO2002005746 A3 WO 2002005746A3 IB 0101252 W IB0101252 W IB 0101252W WO 0205746 A3 WO0205746 A3 WO 0205746A3
Authority
WO
WIPO (PCT)
Prior art keywords
tannates
tannate
isopropanol
tannic acid
antihistamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/001252
Other languages
English (en)
Other versions
WO2002005746A2 (fr
Inventor
Bakulesh Mafatlal Khamar
Chidambaram Venkate Srinivasan
Jayati Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cadila Pharmaceuticals Ltd
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of WO2002005746A2 publication Critical patent/WO2002005746A2/fr
Publication of WO2002005746A3 publication Critical patent/WO2002005746A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Des antihistamines sont disponibles sous forme de bases libres ainsi que sous forme de sels, comme du chlorhydrate, du maléate, tannate, etc.. Il est souvent nécessaire d'utiliser des antihistamines sous forme de sel de tannate car ces sels sont généralement stables et peuvent être administrés sous ces formes sans effets secondaires défavorables. L'acide tannique, également connu sous le nom du tanin, est une substance naturelle. L'acide tannique, qui est commercialisé, contient généralement environ 5 % d'eau, présente un poids moléculaire de 1700 environ, et est généralement produit à partir de la noix de galle turque ou chinoise. Les tannates d'antihistamines, actuellement fabriqués, sont relativement impurs. Ces tannates sont obtenus en faisant réagir une base libre d'antihistamine avec de l'acide tannique et en utilisant un solvant volatile, de l'isopropanol (IPA), on obtient ainsi un rendement d'environ 70 % avec des produits de décomposition, par exemple, de 2 à 5 % avec une quantité significative de solvant volatile, l'isopropanol (6 10%) restant avec le produit qui ne peuvent pas être extraits. Selon la présente invention, pour des types spécifiques de tannates, l'isopropanol (IPA) est extrait en ajoutant de l'eau tout en mélangeant et dispersant le gateau mouillé de tannate. Il est ensuite filtré et le résidu de tannate est séché pour obtenir un tannate de qualité pharmaceutique. Les tannates comme le tannate de chlorphéniramine et les tannates de pyrilamine ont été préparés par ce procédé.
PCT/IB2001/001252 2000-07-14 2001-07-13 Procede de fabrication des tannates de qualite pharmaceutique Ceased WO2002005746A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN662MU2000 2000-07-14
IN662/MUM/2000 2000-07-14

Publications (2)

Publication Number Publication Date
WO2002005746A2 WO2002005746A2 (fr) 2002-01-24
WO2002005746A3 true WO2002005746A3 (fr) 2002-05-02

Family

ID=11097265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001252 Ceased WO2002005746A2 (fr) 2000-07-14 2001-07-13 Procede de fabrication des tannates de qualite pharmaceutique

Country Status (1)

Country Link
WO (1) WO2002005746A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670370B1 (en) 2001-12-14 2003-12-30 Jame Fine Chemicals, Inc. Dextromethorphan tannate
US6833360B2 (en) 2001-12-14 2004-12-21 Jame Fine Chemicals, Inc. Process for preparing pseudoephedrine tannate

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132827A1 (en) * 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US20030114535A1 (en) 2001-12-14 2003-06-19 Jame Fine Chemicals, Inc. Dextrochlorpheniramine tannate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282789A (en) * 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US5663415A (en) * 1996-06-28 1997-09-02 Jame Fine Chemicals, Inc. Process for preparing antihistamine tannates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282789A (en) * 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US5663415A (en) * 1996-06-28 1997-09-02 Jame Fine Chemicals, Inc. Process for preparing antihistamine tannates

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670370B1 (en) 2001-12-14 2003-12-30 Jame Fine Chemicals, Inc. Dextromethorphan tannate
US6833360B2 (en) 2001-12-14 2004-12-21 Jame Fine Chemicals, Inc. Process for preparing pseudoephedrine tannate

Also Published As

Publication number Publication date
WO2002005746A2 (fr) 2002-01-24

Similar Documents

Publication Publication Date Title
CA2290918A1 (fr) Derives bicycliques heteroaromatiques utiles comme agents anticancereux
WO2002022598A8 (fr) Derives de quinolinone
WO2001035957A3 (fr) Sels stables de nouveaux derives de 3,3-diphenylpropylamines
WO2000045770A3 (fr) Preparations de lecithine comprimees
WO2003086392A3 (fr) Procede pour preparer une composition pharmaceutique finement auto-emulsifiable
EP1520850A3 (fr) Dienamides conjugues, leurs procedes de preparation, compositions les contentant et leurs utilisations
HUT55011A (en) Process for producing imidazolylalkenoic acids and pharmaceutical compositions comprising such compounds as active ingredient
BRPI0414010B1 (pt) uso cosmético de biotina em conjunto com ascorbil fosfato de sódio ou um hidrato do mesmo para a produção de uma composição para clarear a pele, para corrigir irregularidades na cor da pele e/ou para tratar lentiginas senis
HU222774B1 (hu) Kolinészteráz-inhibitor hatású geneszerinszármazékok és ezeket tartalmazó gyógyszerkészítmények
WO2002005746A3 (fr) Procede de fabrication des tannates de qualite pharmaceutique
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物,包含該衍生物的藥物組合物以及製備該活性物質的方法
EP3662891B1 (fr) Composition pour prévenir la chute des cheveux ou stimuler la pousse des cheveux
EP3461475A1 (fr) Composition pharmaceutique contenant un sel d'amine sympathomimétique et un additif co-distillable
US6939856B2 (en) Method for preparing dexchlor tannate
WO2002005745A3 (fr) Procede de preparation de tannates de qualite pharmaceutique
US6881744B2 (en) Carbinoxamine tannate
WO2002005747A3 (fr) Procede de fabrication de tannates de qualite pharmaceutique
JP2001316263A (ja) 化粧品用、または特に皮膚科の医薬用抗アレルギー性組成物の調製のためのククルビチンの用途、及び、その投与を含む方法
WO2004069145A3 (fr) Nouveaux composes anticancereux, procede de preparation de ces derniers et compositions pharmaceutiques contenant ces composes
US20050202050A1 (en) Single tank process for preparing tannate liquid and semi-solid dosage forms
MXPA06002066A (es) Sales de tanato de fenileprina, tanato de pirilamina, y tanato de dextrometorfan en composiciones farmaceuticas.
JP2022008886A (ja) 5α-レダクターゼ阻害剤、及び脱毛症の予防治療用又は育毛促進用組成物、並びに頭皮中の5α-レダクターゼを阻害する方法及び育毛促進方法
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
WO2004016589A3 (fr) Procede de production de donepezil hydrochlorure tres pur
WO1998056759A3 (fr) Nouveaux derives de pentaerythrite, leur production, leur utilisation et intermediaires pour leur synthese

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA MX US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase